TLK · US market

Telkom Indonesia Persero Tbk PT

Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.

Market cap US$10.82bnFinancials dated 30 June 2026Price dated 20 November 2026

Core valuation

Trailing P/EUnavailable
Latest-quarter run-rate P/E7.62×
Trailing P/S1.28×
Latest-quarter run-rate P/S1.24×

Calculation inputs

Trailing earnings
Unavailable
Latest-quarter run-rate earnings
US$1.42bn
Latest fiscal-year earnings
US$1.01bn
Trailing revenue
US$8.46bn
Latest-quarter run-rate revenue
US$8.75bn
Latest fiscal-year revenue
US$8.30bn

Featured ETF and mutual-fund exposure

These public funds report this company in their latest disclosed holdings.

  • IDX · VanEck Indonesia Index ETF6.08% weight · Holdings dated 30 June 2026
  • PID · Invesco International Dividend Achievers ETF2.94% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 205 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • TDIV · First Trust NASDAQ Technology Dividend Index Fund0.17% weight · Holdings dated 30 June 2026
  • AVES · Avantis Emerging Markets Value ETF0.16% weight · Holdings dated 31 May 2026Holdings available · disclosure too old for reliabilityHoldings dated 31 May 2026 are 174 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • AVSE · Avantis Responsible Emerging Markets Equity ETF0.14% weight · Holdings dated 31 May 2026Holdings available · disclosure too old for reliabilityHoldings dated 31 May 2026 are 174 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • AVXC · Avantis Emerging Markets Ex-China Equity ETF0.12% weight · Holdings dated 31 May 2026Holdings available · disclosure too old for reliabilityHoldings dated 31 May 2026 are 174 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • AVEM · Avantis Emerging Markets Equity ETF0.07% weight · Holdings dated 31 May 2026Holdings available · disclosure too old for reliabilityHoldings dated 31 May 2026 are 174 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • APIE · ActivePassive International Equity ETF0.06% weight · Holdings dated 31 May 2026Holdings available · disclosure too old for reliabilityHoldings dated 31 May 2026 are 174 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • DEXC · Dimensional Emerging Markets ex China Core Equity ETF0.04% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 205 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.
  • DFEM · Dimensional Emerging Markets Core Equity 2 ETF0.01% weight · Holdings dated 30 April 2026Holdings available · disclosure too old for reliabilityHoldings dated 30 April 2026 are 205 days old, beyond this source’s 155-day reliability limit. Ratios remain available as dated research; calculations are unchanged and are not labelled reliable.

Sources and limitations

Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.

Open financial source

Financials as of 30 June 2026. Informational research, not investment advice.